NCT06440408View on ClinicalTrials.gov

Calculating Wall Shear Stress in Infant Pulmonary Veins

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

March 31, 2027

Conditions
Pulmonary Vein Stenosis
Interventions
DRUG

Ferumoxytol

Ferumoxytol will be used as a contrast agent for the cMRI

Trial Locations (1)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER